Specifically, the company states that FDA-approved GLP-1/GIP medications for weight loss and type 2 diabetes, including Ozempic, Wegovy, Zepbound, and Mounjaro, "may also be eligible for coverage." The company further states that while they "assist with prior authorizations and prescription submissions," they "do not bill insurance directly." This distinction is important: the compounded GLP-1 program itself is described as a cash-pay arrangement, but the company also facilitates access to FDA-approved branded medications that may have insurance pathways
DONT JUST TAKE OUR WORD FOR IT True Stories Of Transformation My clinician is amazing
They are not required to demonstrate efficacy, and they do not need to prove that their delivery method works as claimed before reaching the market
[Google Scholar] 84.Merino B, Dez-Fernndez C, Ruiz-Gayo M, Somoza B
A patient who wants to be prepared for the first visit should come ready to discuss their full medical history verbally, including any family history of thyroid cancer or MEN-2, any history of pancreatitis or eating disorders, any current mental-health care, and any medications or allergies
Weight loss vendor landscape Weight loss vendors are actively marketing to employers
